| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/09/2005 | US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 06/09/2005 | US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 06/09/2005 | US20050124578 Aqueous compositions containing metronidazole |
| 06/09/2005 | US20050124574 Purine derivatives |
| 06/09/2005 | US20050124551 Or its cystine-coupled dimer, mixed with a nonsteroidal antiinflammatory agent used to treat contact dermatitis. |
| 06/09/2005 | US20050124545 Cosmetic or parmaceutical composition containing peptides |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124042 Method for expression of heterologous proteins in yeast |
| 06/09/2005 | US20050124036 Method for producing recombinant proteins in micro-organisms |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches |
| 06/09/2005 | US20050123671 Incorporating trehalose into an edible aqueous system containing alpha glucosyl hesperidin or catechin or both followed by sterilization |
| 06/09/2005 | US20050123636 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect |
| 06/09/2005 | US20050123577 Use of prostaglandin EP-3 receptor antagonists as cosmetic agents for attenuating, reducing or stopping the loss of head hair and other hairs |
| 06/09/2005 | US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| 06/09/2005 | US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | DE10352369A1 Verwendung von Licocalchon A oder eines Licocalchon A enthaltenden Extraktes aus Radix Glycyrrhizae inflatae gegen postinflammatorische Hyperpigmentierung Use of licochalcone A or A licochalcone containing extract of Radix Glycyrrhizae inflatae postinflammatory hyperpigmentation against |
| 06/09/2005 | DE10352368A1 Treatment of insect bites using licochalcone A or extracts of Radix Glycyrrhizae inflatae, provides long-lasting suppression of redness, itching and swelling |
| 06/09/2005 | DE10352367A1 Treatment of rosacea using licochalcone A or extracts of Radix Glycyrrhizae inflatae, provides long-lasting suppression of redness and inhibits further outbreaks |
| 06/09/2005 | DE10066022B4 Medicament useful for treating immunological disorders, Alzheimer's disease, diabetes and obesity comprises a nettle extract prepared using an extractant other than water, ethanol and their mixtures |
| 06/09/2005 | CA2547467A1 Piperidine compound and method for producing same |
| 06/09/2005 | CA2536181A1 Polymer compositions and methods for their use |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538160A1 Substituted Isoquinolin-3-carboxyamides, their preparation and medical use |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537867A1 Method of photodynamic diagnosis for vascular diseases |
| 06/08/2005 | EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof |
| 06/08/2005 | EP1537855A1 Cosmetic composition comprising licochalcone A or an extract of Glycyrrhiza inflatae comprising licochalcone A and an organic thickener |
| 06/08/2005 | EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 06/08/2005 | EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 06/08/2005 | EP1537106A1 Dihydropyrazolopyridine compounds |
| 06/08/2005 | EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1537086A2 Novel phenanthridines |
| 06/08/2005 | EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1537073A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 06/08/2005 | EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 06/08/2005 | EP1536807A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 06/08/2005 | EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/08/2005 | EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 06/08/2005 | EP1536764A2 Cosmetic composition for fighting against skin ageing |
| 06/08/2005 | EP1536697A1 Composition containing in combination at least one gourd oil and at least one borage oil, use thereof as medicine, as dermatological or dermato-cosmetic agent |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1432427B1 Composition of hypochlorous acid and its applications |
| 06/08/2005 | EP1373231B1 3-heterocyclyl-propano-hydroxamic acid as pcp inhibitors |
| 06/08/2005 | EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 06/08/2005 | EP1265595B1 Stabilized ascorbic acid solutions |
| 06/08/2005 | EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 06/08/2005 | EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 06/08/2005 | EP1176146B1 Carbamoyl tetrahydropyridine derivatives |
| 06/08/2005 | EP1165031B1 Resorcinol composition |
| 06/08/2005 | CN1625603A Genetic polymorphisms in the preprotachykinin gene |
| 06/08/2005 | CN1625558A Aza-arylpiperazines |
| 06/08/2005 | CN1625400A 2, 4-pyrimidinediamine compounds and their uses |
| 06/08/2005 | CN1625387A Cosmetic or dermatological use of vitamin A or the esters thereof in combination with a partly methylated beta-cyclodextrin |
| 06/08/2005 | CN1625385A Lipase inhibiting composition |
| 06/08/2005 | CN1625384A Topical dapsone for the treatment of acne |
| 06/08/2005 | CN1623597A Canine oil ointment for curing burn and stopping pain |
| 06/08/2005 | CN1623595A Ointment for curing burn and scald |
| 06/08/2005 | CN1623587A Skin medicine and its preparation method |
| 06/08/2005 | CN1623583A Soft ointment for treating skin dermatomycosis |
| 06/08/2005 | CN1623579A Medicine for treating burn and scald |
| 06/08/2005 | CN1623547A Medical use of artificial lywrine |
| 06/08/2005 | CN1623546A Compound preparation for treating acne |
| 06/08/2005 | CN1623541A Application of aloelactone in preparation of medicine |
| 06/08/2005 | CN1623532A Plant source acne fast detoxifying cleaning skin protecting emulsion and its preparation method |
| 06/08/2005 | CN1623400A Skin disinfectant and its preparation method |
| 06/08/2005 | CN1205332C Hair-nourishing hair-growing liquor |
| 06/08/2005 | CN1205181C Matrix metalloproteinase inhibitors |
| 06/08/2005 | CN1204918C Medicine for treating scald and burn and its preparing method |
| 06/08/2005 | CN1204913C Medical wine for nourishing kidney and hair growing and its preparing process |
| 06/08/2005 | CN1204912C External medicine for treating burn and scald, soft tissue injury and skin disease |
| 06/08/2005 | CN1204909C Ointment made of Chinese medicine herbs for treating refractory bedsore |
| 06/08/2005 | CN1204907C Chinese medicine composite external liniment for treating alopecia areata |
| 06/08/2005 | CN1204904C Process for preparing liniment to treat leukoderma |
| 06/08/2005 | CN1204899C Chinese medicine (instant particles) for treating intractable tined and its preparing process |
| 06/08/2005 | CN1204884C N-acetyl-L cysteine for preparing medicine for treating epithelial tumous |
| 06/08/2005 | CN1204869C Oxidation dyeing process and oxidation dye composition for keratin fibres which comprises cationic amphiphilic polymer |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903199 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 06/07/2005 | US6903135 Methods and products related to 16-HETE analogs |
| 06/07/2005 | US6903134 Formulation comprising benzofuranone derivatives for protection against oxidative stress |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/07/2005 | US6903098 Use of phthalazine derivatives |
| 06/07/2005 | US6903096 Quinazoline derivatives as medicaments |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |